Michael McAlpine is a Professor in the Mechanical Engineering department at the University of Minnesota . He also holds affiliations with the Biomedical Engineering and Electrical and Computer Engineering departments. His research focuses on 3D printing functional materials & devices , Nanoscale inks , Biomedical devices , Bioelectronics , and Flexible Microsystems . Research Interests : 3D Printing, Biomedical Engineering, Nanotechnology, Flexible Electronics, Microfluidics Labs : ME 361/363 Contact : mcalpine@umn.edu , (612) 626-3303, ME 117 Recent Research Trends include 3D Printed Biomedical Devices , Flexible Electronics , and Bioprinting Applications . His work spans from Spinal Organoid Formation to Programmable Drug Release Capsules . Scientific Award : Circulation Research 2020 Best Manuscript Award
Weiqiang Chen is a Professor of Mechanical and Biomedical Engineering at New York University's Tandon School of Engineering and Director of Research and PhD Programs. He holds a joint appointment at NYU Langone's Perlmutter Cancer Center as a Faculty Member of the Tumor Immunology Research Program. B.S. in Physics (Nanjing University, 2005) M.S. in Electrical Engineering (Shanghai Jiao Tong University, 2008) M.S. in Electrical and Computer Engineering (Purdue University, 2009) Ph.D. in Mechanical Engineering (University of Michigan, 2014) His research focuses on Lab-on-a-Chip , Organ-on-Chip systems, Biomaterials , and Mechanobiology , with applications in cancer biology, stem cell engineering, and immune monitoring. He pioneers microfabrication technologies for real-time observation of cellular interactions, including CAR T-cell immunotherapy efficacy and tumor microenvironment dynamics. Recent grants include NSF funding for leukemia bone marrow niche modeling, NIH Trailblazer Awards for glioblastoma immunotherapy research, and collaborations with the Arthritis Foundation for synovium-on-chip rheumatoid arthritis studies. His work has been supported by over $2M in federal and institutional research funding. National Science Foundation (NSF) grants for leukemia-on-chip and glioblastoma modeling National Institutes of Health (NIH) awards for immunotherapy research American Heart Association fellowships and institutional training programs Chen's scientific awards include the American Heart Association Fellow distinction, multiple Young Investigator Awards from Lab on a Chip and Biomedical Engineering Society, and recognition for his dissertation on nanotopography in stem cell differentiation. He leads the Applied Micro-Bioengineering Laboratory (AMBL) , which develops microphysiological systems for drug testing and personalized medicine. His team has created the first immunocompetent leukemia-on-a-chip for CAR T-cell therapy screening and glioblastoma models that enable patient-specific immunotherapy validation.
Professor Robert McLaughlin is a faculty member in the School of Biomedicine at the University of Adelaide, affiliated with the Faculty of Health and Medical Sciences. He leads the Bioengineering Imaging Group and serves as Managing Director of the start-up Miniprobes. His research focuses on developing optical imaging technologies, including non-invasive tools for blood flow assessment and miniaturized imaging probes. He has secured over $14M in research grants and holds an h-index of 45 with 98 journal papers, 7 patents, and 2 book chapters. Prof. McLaughlin’s career includes roles at the University of Oxford and Siemens Medical Solutions, followed by academic leadership since 2007. His innovations span optical coherence tomography (OCT), fluorescence imaging, and dual-modality systems for clinical applications. Awards include the 2014 WA Innovator of the Year, 2015 Australian Innovation Challenge, and 2016 South Australian Premier’s Research Fellowship. His research emphasizes practical medical solutions, such as imaging needles for deep-tissue diagnostics and optical devices for real-time surgical monitoring. The Bioengineering Imaging Group collaborates with industry and academia to translate technologies into clinical practice.
Associate Professor Anna Waterhouse is a Robinson Fellow and Head of the Cardiovascular Medical Devices Group at the Charles Perkins Centre, School of Medical Sciences, University of Sydney. Her research focuses on developing antithrombogenic materials and bioinspired medical devices to address cardiovascular diseases. She holds affiliations with the University of Sydney Nano Institute and the Australiasian Society for Biomaterials and Tissue Engineering as Treasurer and Secretary. Education includes a BSc (1st class hons) in Cell Biology from the University of Manchester and a PhD in bioengineering from the University of Sydney. She completed postdoctoral training at Harvard University’s Wyss Institute. Research interests span biomaterials, thrombosis prevention, and medical device engineering. Key projects include liquid-infused surfaces for anti-thrombotic coatings and biomimetic in vitro models. Her work integrates bioengineering, nanotechnology, and surface modification to improve medical device compatibility. Scientific awards include the Robinson Fellowship and CPC Mid-Career Researcher Support Award. Grants funded by ARC, Heart Foundation, and NSW Health support projects like slippery nano-coatings for medical devices. She advises PhD students in biomolecular nanotechnology, endothelial cell studies, and DNA nanostructures. Labs and collaborations involve Sydney Nano Institute and Charles Perkins Centre, focusing on translational research in cardiovascular and biomedical engineering.
Aditi Das is a Full Professor in the School of Chemistry and Biochemistry at the Georgia Institute of Technology, College of Sciences. She leads the Das Laboratory, which focuses on the biochemistry and chemical biology of lipids, particularly studying cytochrome P450 enzymes and their role in lipid metabolism, endocannabinoid systems, and inflammatory pathways. Her educational background includes: B.Sc. in Chemistry from St. Stephen's College M.Sc. in Chemistry from Indian Institute of Technology, Kanpur (I.I.T) Ph.D. in Chemistry from Princeton University Postdoctoral research at Northwestern University (NSF-NSEC fellow) and Beckman Institute for Advanced Science and Technology, University of Illinois UC Professor Das's research interests center around understanding the physiological role of lipids in sustaining homeostasis and their implications in disease states such as neurodegenerative disorders, cancer, and cardiovascular diseases. Her laboratory specializes in: Enzymology of cytochrome P450s, particularly CYP2J2 epoxygenase Metabolism of ω-3 and ω-6 fatty acids and their derivatives Minor cannabinoid metabolism by cytochrome P450 enzymes Discovery of novel anti-inflammatory lipid metabolites and endocannabinoids Mechanistic studies of membrane proteins using nanodisc technology Her work bridges biochemistry, chemical biology, and pharmacology to uncover novel therapeutic targets related to lipid signaling pathways. Analysis of Professor Das's recent publications (2023-2025) reveals a strong focus on cannabinoid metabolism by cytochrome P450 enzymes, with particular emphasis on how these metabolic processes generate bioactive compounds that interact with the endocannabinoid system. Her research increasingly explores the therapeutic potential of omega-3 derived endocannabinoid epoxides in inflammatory and neurodegenerative conditions. The use of nanodisc technology for studying membrane proteins in near-native environments remains a consistent methodological thread throughout her work, enabling detailed mechanistic insights into enzyme function. Professor Das has received numerous prestigious awards recognizing her research excellence and teaching: 2024 NIH Outstanding Researcher Award (MIRA R35) for established investigators 2024 Vasser Woolley Faculty Fellowship 2023 Plenary Lecture at the International Society of the Study of Xenobiotics (ISSX) 2021 E.L.R. Stokstad Award 2019-2021 List of Teachers Ranked as Excellent 2019 Eicosanoid Research Foundation Young Investigator Award 2019 Zoetis Research Excellence Award 2019 Mary Swartz Rose Young Investigator Award 2015 National Scientist Development Award from the American Heart Association 2022 El Sohly Award from the American Chemical Society Professor Das actively mentors a diverse group of students and postdoctoral researchers, with several former lab members now holding faculty positions or working at prestigious institutions. Her laboratory has secured significant funding from NIH, NSF, and other sources to support research on lipid metabolism, cannabinoid pharmacology, and membrane protein biochemistry. Notable grants include an NIH R35 Outstanding Investigator Award (MIRA), an NIH R21 grant from NIDA, and multiple collaborative grants with other research groups. The Das Laboratory operates within the Petit Institute of Bioengineering and Biosciences (IBB) at Georgia Tech, utilizing state-of-the-art facilities for biochemical and biophysical studies. The lab specializes in nanodisc technology to study membrane proteins in near-native environments, with particular expertise in cytochrome P450 enzymes and their interactions with lipid substrates. Recent work has expanded into collaborative projects involving lipidomics, structural biology, and translational applications of lipid signaling research.
Gaetano Valenza is an Associate Professor of Bioengineering at the University of Pisa, Italy, where he leads the Neuro-Cardiovascular Intelligence Lab at the Enrico Piaggio Research Centre. He holds affiliations with the Neuroscience Statistics Research Laboratory at MIT and has served as a Research Fellow at Harvard Medical School and Massachusetts General Hospital. His academic work spans bioengineering, computational physiology, and affective computing. His research focuses on statistical and nonlinear biomedical signal and image processing , cardiovascular and neural modeling , and physiologically interpretable artificial intelligence . He develops wearable systems for physiological monitoring, with applications in autonomic nervous system assessment, brain-heart interactions, and mental health. His work has led to novel metrics such as the Sympathetic and Parasympathetic activity indices derived from ECG. The 15 most recent publications reflect a consistent trend in brain-heart interplay , complexity analysis of physiological signals , explainable AI in healthcare , and virtual reality applications in mental health . His work integrates advanced signal processing, nonlinear dynamics, and machine learning to decode emotional and cognitive states from physiological data. Dr. Valenza is a Senior Member of IEEE and serves on several technical committees. He is an active editorial leader, currently serving as Associate Editor for IEEE-EMBC , Plos One , Complexity , and Scientific Reports , and has guest-edited special issues in Philosophical Transactions of the Royal Society A and IEEE Journal of Biomedical and Health Informatics . He has led or participated in numerous international research projects, including FP7 and H2020 initiatives such as NEVERMIND and EXPERIENCE. He teaches courses in Biostatistics, Probability & Biostatistics, and Advanced Image Processing at the University of Pisa. As lab head and project coordinator, he leads a multidisciplinary team working on neuro-cardiovascular intelligence, wearable systems, and AI-driven mental health interventions.
W. Hong Yeo is a Professor in the Woodruff School of Mechanical Engineering and Program Faculty in Bioengineering at the Georgia Institute of Technology, where he also directs the WISH Center. He holds adjunct appointments in the Wallace H. Coulter Department of Biomedical Engineering. Previously, he was an Assistant Professor at Virginia Commonwealth University (2014-2016) and a postdoctoral fellow at the University of Illinois Urbana-Champaign's Beckman Institute. Dr. Yeo's research integrates nanomechanics, soft materials, and nano-microfabrication to develop bio-interfaced systems. Key areas include: Flexible Bioelectronics : Wearable/implantable sensors for health monitoring Human-Machine Interfaces : Neural prosthetics and soft robotics Translational Nanoengineering : Nanoparticle biosensing and diagnostics His publications (2023-2025) demonstrate strong focus on wireless health technologies, including multi-modal wearable systems, implantable sensors for cardiovascular/neurological monitoring, and AI-integrated diagnostics. Trends show increasing emphasis on closed-loop therapeutic systems and scalable manufacturing. Awards & Recognition : BMES Innovation and Career Development Award Virginia Commercialization Award Blavatnik Award Nominee NSF Summer Institute Fellowship Research funding sources include MEDARVA Foundation, NIH, DARPA, and industry partners like CooperVision. He leads the Center for Human-Centric Interfaces & Engineering , developing next-generation bio-interfaced systems.
Foteini Mourkioti is an Associate Professor at the University of Pennsylvania's Perelman School of Medicine , with a joint appointment in the Graduate Groups of Cell and Molecular Biology and Bioengineering . She co-directs the Musculoskeletal Regeneration Program at the Penn Institute of Regenerative Medicine and leads the McKay Orthopaedic Research Laboratory . Research Interests : Muscle Stem Cell Biology Mechanobiology Muscle Regeneration Telomere Biology in Muscular Diseases Fibrodysplasia Ossificans Progressiva (FOP) Cardiomyopathy and Aging Key Research Contributions : Developed the Pax7EGFP mouse model for real-time muscle stem cell tracking Discovered telomere shortening as a critical factor in Duchenne Muscular Dystrophy Elucidated the role of NF-κB in muscle stem cell dysfunction Identified Piezo1's role in stem cell morphological states Characterized fibro-adipogenic progenitor dynamics in FOP Scientific Awards : NIH/NHLBI R01 grant recipient (2019) NASA grant awardee (2020, 2017) American Heart Association grant (2017) Muscular Dystrophy Association grant (2019) University Research Foundation grant (2018) Publications & Collaborations : Over 25 publications in high-impact journals like Science Advances , Nature Protocols , and Cell Reports . Collaborates with Penn Cardiovascular Institute and Pennsylvania Muscle Institute.
David N. Ku is the Lawrence P. Huang Endowed Chair for Engineering Entrepreneurship and Regents' Professor at Georgia Institute of Technology. He holds appointments in the School of Mechanical Engineering (Woodruff School) within the College of Engineering. His research focuses on biofluid mechanics, medical device innovation, and translational technology, with emphasis on thrombosis mechanisms and vascular diseases. Education: M.D. from Emory University (1984); Ph.D. and M.S. from Georgia Tech (1983, 1982); B.A. from Harvard University (1978). Research interests include unsteady fluid dynamics in vascular systems, nanoparticle medical devices for thrombosis prevention, and porous thrombus applications for hemostasis. His work bridges bioengineering with entrepreneurship, teaching product development at the Business School and collaborating with Emory University, Paris Tech-Mines, and ETH Zurich. Key awards include the American Institute for Medical and Biological Engineering Fellowship, DLA Piper Inventor of the Year, and NSF Presidential Young Investigator Award. His research is funded by NIH, NSF, and industry partners. Labs/Teams: Leads a lab using microfluidics and computational mechanics for vascular disease solutions. Collaborates on technologies to address post-partum hemorrhage and traumatic bleeding.
John C. Doyle is the Jean-Lou Chameau Professor of Control and Dynamical Systems, Electrical Engineering, and BioEngineering at the California Institute of Technology (Caltech), where he holds appointments in the Division of Engineering and Applied Science with primary affiliation in the Control and Dynamical Systems Department. His research bridges theoretical foundations with applications across biological, technological, medical, and ecological networks. He earned a BS and MS in Electrical Engineering from MIT (1977) and a PhD in Mathematics from UC Berkeley (1984), followed by consultancy at Honeywell Systems and Research Center (1976-1990). MIT: BS & MS in Electrical Engineering (1977) UC Berkeley: PhD in Mathematics (1984) Doyle's research centers on universal laws and architectures in complex systems, emphasizing robustness-efficiency tradeoffs, speed-accuracy tradeoffs (SATs), diversity-enabled sweet spots (DeSS), bowtie/hourglass structures, and evolvability. His work pioneers System Level Synthesis (SLS) for control systems with sparse, local, saturating, delayed, noisy, quantized, and distributed (SLSDNQD) components, integrating control theory, computation, communication, and machine learning to address challenges from neural networks to infrastructure resilience. Key concepts include virtualization, horizontal transfer, and virality in multiscale systems. Analysis of his publication trends reveals consistent interdisciplinary impact across neuroscience (brain connectivity modeling), systems biology (metabolic oscillations), network science (internet topology), and physics (turbulence, earthquakes), with recurring themes of robust-efficiency limits and architectural principles governing complex networks. His work demonstrates exceptional translation from abstract theory to practical tools like the Matlab Robust Control Toolbox and Systems Biology Markup Language (SBML). His scientific recognition includes: 1990 IEEE Baker Prize (ranked among top 10 most important mathematics papers 1981-1993) Three IEEE Automatic Control Transactions Awards (1998, 1999, 2021) ACM Sigcomm Paper Prize (2004) and Test of Time Award (2016) IEEE Control Systems Field Award (2004) Multiple early-career honors including IEEE Centennial Outstanding Young Engineer (1984) Doyle has mentored generations of students whose contributions include foundational software tools adopted globally. His research has secured sustained funding from NSF, NIH, and other agencies supporting theoretical advances in control frameworks and their applications to biomedical systems, network infrastructure, and environmental modeling. The SBML initiative exemplifies his group's impact in standardizing computational biology research. He leads a highly collaborative research ecosystem at Caltech that integrates engineers, biologists, neuroscientists, and computer scientists to develop universal principles for complex networks. Current efforts focus on translating theoretical insights into health technologies, resilient infrastructure, and climate-responsive systems through the application of robust-efficiency frameworks to emerging challenges in cyber-physical and biological domains.
Dr. Craig S. Levin is a Professor of Radiology at Stanford University's Molecular Imaging Program at Stanford (Nuclear Medicine), with courtesy appointments in Physics, Electrical Engineering, and Bioengineering. He also holds memberships in Bio-X, the Cardiovascular Institute, the Wu Tsai Human Performance Alliance, and the Stanford Cancer Institute. Dr. Levin received his B.S. Summa Cum Laude in Physics and Mathematics from UCLA in 1985, followed by M.S., M.Phil., and Ph.D. degrees in Physics from Yale University in 1987 and 1993. His educational achievements were recognized with multiple honors including Phi Beta Kappa, Sigma Pi Sigma, and various departmental awards at UCLA. Dr. Levin's research focuses on the development of novel instrumentation and software algorithms for molecular imaging. His work spans medical physics, biomedical engineering, and instrumentation development with specific emphasis on positron emission tomography (PET), gamma camera technology, and multimodal imaging systems. His laboratory explores new concepts in radiation detection, image reconstruction algorithms, and the application of these technologies to cancer, heart disease, and neurological disorders. A notable aspect of his research involves pushing the physical limits of sensitivity and spatial, spectral, and/or temporal resolutions in imaging systems. His recent publications demonstrate a strong focus on enhancing PET technology, particularly time-of-flight capabilities, with significant work on improving coincidence timing resolution, developing MR-compatible PET systems, and applying deep learning techniques to image reconstruction and normalization. His research shows a clear trajectory toward higher resolution imaging with improved quantitative accuracy for both clinical and preclinical applications. Dr. Levin's scientific achievements have been recognized with numerous awards: American Institute for Medical and Biological Engineering's College of Fellows Academy of Radiology Research Distinguished Investigator Recognition Award National Research Service Award from NIH (1993-5) Pilot Research Award from the Society of Nuclear Medicine (1996) Multiple honors from UCLA including Phi Beta Kappa and Sigma Pi Sigma Full Tuition and Research Fellowship and Bates Graduate Fellowship from Yale University As an educator and mentor, Dr. Levin directs the NIH-NCI funded T32 Stanford Molecular Imaging Scholars postdoctoral training program and serves as a Doctoral Dissertation Advisor for students in Bioengineering and Biophysics. He currently advises five postdoctoral scholars and three doctoral candidates. His laboratory, the Molecular Imaging Instrumentation Laboratory, comprises approximately 20 members who work on developing new imaging technologies and translating them into clinical applications. Dr. Levin has secured substantial NIH funding as Principal Investigator along with grants from other government agencies, industry partners, and private institutions to support his research program. Dr. Levin's Molecular Imaging Instrumentation Laboratory is at the forefront of developing new imaging technologies that bridge physics, engineering, and medicine. The lab focuses on creating instrumentation for in vivo imaging of cellular and molecular signatures of disease, with particular emphasis on pushing the physical limits of imaging performance. Their work spans computer modeling, sensor development, electronics design, data acquisition systems, and advanced image processing algorithms. The lab maintains strong industry partnerships to translate their innovations into products used for patient care worldwide.
Kristina Schoonjans is an Associate Professor at EPFL’s School of Life Sciences, where she leads the Laboratory of Metabolic Signaling (UPSCHOONJANS). Her research focuses on the molecular mechanisms of bile acid signaling, nutrient sensing, and intermediary metabolism, particularly in the context of metabolic disorders such as obesity, fatty liver disease, and cancer. She investigates how the liver-gut-brain axis integrates metabolic signals through nuclear receptors and mitochondrial dynamics. Her research interests include: Bile acid signaling and its role as a hormonal regulator Nutrient and metabolite sensing in energy homeostasis Intermediary metabolism and metabolic disorders Role of nuclear receptors (e.g., TGR5, LRH-1) in liver, gut, and adipose tissue Mitochondrial dynamics and fission in metabolic regulation Organoid models for studying liver and intestinal metabolism Systems genetics using BXD mouse populations The most recent articles highlight a strong focus on bile acid signaling, particularly through TGR5 and LRH-1, in regulating metabolic health. Themes include the conversion of white fat to beige fat (beiging), hepatic tumorigenesis, mitochondrial fission, and the use of organoid and genetically engineered mouse models. There is a consistent emphasis on translational applications for obesity, fatty liver disease, and cancer. Scientific honors include: Windaus Prize from the Dr. Falk Foundation (2010, shared with Johan Auwerx) for the discovery of the signaling/endocrine function of bile acids Prof. Schoonjans actively supervises PhD students and has advised numerous doctoral candidates who have since completed their theses. Her lab is supported by multiple grants from Swiss and international funding agencies, including the Swiss National Science Foundation, EPFL, CONACYT, and the Foundation for Health and Education. She teaches in several doctoral programs at EPFL, including Life Sciences Engineering, and contributes to education through the SSV and EDBB/EDCB/EDMS-ENS programs. The Schoonjans Lab brings together scientists, doctoral assistants, and technicians working on projects related to metabolic signaling. The team uses advanced techniques such as genetically modified mouse models, organoid cultures, and multi-omics (metabolomics, proteomics, transcriptomics) to study the liver-gut and brain-liver axes. The lab has a strong track record of high-impact publications and collaborations with institutions worldwide.
Prof. Andreas Bausch holds the Heinz Nixdorf Endowed Chair of Cell Biophysics at the Technical University of Munich (TUM) within the TUM School of Natural Sciences . His research focuses on cellular biophysics , particularly the mechanical properties of cytoskeletal networks and self-organization mechanisms in biological systems, with applications in biomimetic materials and organoid modeling. Research Areas : Cytoskeletal mechanics, active matter systems, organoid morphogenesis, integrin signaling, synthetic cell models Techniques : Microrheology, in vitro reconstitution, microfluidics, advanced imaging His work has produced over 100 publications in Nature, Science, PNAS , and Physical Review Letters , with recent emphasis on pancreatic cancer organoids and artificial cell membranes . Key findings include: Discovery of topological excitations governing endothelial cell ordering Elucidation of PIP2/PIP3 regulation in integrin phase separation Development of 3D patterned organoid systems for drug screening Major awards include: ERC Synergy Grant (2018) ERC Advanced Grant (2012) ERC Starting Grant (2011) Berlin-Brandenburg Academy of Sciences Prize (2014) He serves as founding director of the Center for Functional Protein Assemblies (CPA) since 2015 and teaches biomechanics , biophysics , and protein assemblies at TUM. His lab investigates both fundamental biophysical principles and their medical applications in cancer and cardiovascular systems.
Dr. Su Ryon Shin is an Assistant Professor in the Division of Engineering in Medicine at Harvard Medical School and Brigham and Women's Hospital (BWH) in Cambridge, MA. She leads an active research laboratory focused on bioengineering, tissue engineering, and regenerative medicine, with particular expertise in 3D bioprinting, biomaterials, and organ-on-a-chip technology. Her research interests span biohybrid robotics, decellularized extracellular matrix, stem cell-based tissue engineering, and volumetric muscle regeneration . Dr. Shin's work integrates advanced biomaterials with cellular systems to create innovative solutions for tissue regeneration and disease modeling. She has pioneered approaches using human stem cell-derived materials for volumetric tissue regeneration and developed biohybrid neuromuscular robots powered by living cardiac muscle cells. Her publication record demonstrates consistent productivity with over 180 publications, including numerous first/senior author papers in high-impact journals like Science Robotics, Advanced Materials, and Nature Reviews Bioengineering . Her work shows a clear progression from fundamental biomaterials development to increasingly complex tissue engineering applications and translational research. Dr. Shin has received significant recognition including being named a 2025 BWH Health & Technology Innovation Awardee , Highly Cited Researcher 2024 by Web of Science, and multiple Stepping Strong Innovator Awards (2015, 2018, 2020). Her research has been featured in Nature Reviews Bioengineering for breakthrough work on biohybrid robots. She actively mentors students and postdocs, with former lab members accepted to prestigious programs like MIT's PhD program in Chemical Engineering. Her collaborative approach is evident through numerous interdisciplinary projects with researchers across Harvard Medical School, BWH, and international institutions.
Chris B. Schaffer is a Professor in the Meinig School of Biomedical Engineering at Cornell University, specializing in developing advanced optical techniques to study neurovascular dynamics in neurological diseases. His lab focuses on Alzheimer’s disease mechanisms, leveraging multiphoton microscopy and in vivo imaging to explore capillary stalling, cerebral blood flow deficits, and their cognitive impacts. He holds a Ph.D. in Physics from Harvard University and postdoctoral training in neuroscience at UC San Diego. Research interests include biomedical imaging instrumentation, neurodegenerative disease modeling, and science education innovation. Awards include AAAS Fellowship (2021), AIMBE Fellowship (2019), and multiple teaching accolades. His work bridges engineering and medicine, with contributions to spinal cord injury studies, epilepsy, and vascular contributions to dementia (VCID). Notable discoveries include identifying neutrophil-induced capillary stalls as a key Alzheimer’s disease mechanism and demonstrating cerebral blood flow improvements can restore memory in mouse models. His lab also develops educational tools emphasizing science as a discovery process, used in K-12 and university settings.
